Ligand profile
PD8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4808 — folyl-polyglutamate synthetase
Identifiers
Database identifiers and provenance.
- Ligand ID
PD8- PDB
1w78- UniProt (similar protein)
P08192- Target protein
- VK055_4808
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 193.4
- −1 ≤ LogP ≤ 5 0.16
- MW ≤ 500 Da 392.3
- LogP ≤ 5 0.16
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 193.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1C(=O)OP(=O)(O)O)NCc2cnc3c(n2)C(=O)NC(=N3)Nc1cc(ccc1C(=O)OP(=O)(O)O)NCc2cnc3c(n2)C(=O)NC(=N3)N
InChI=1S/C14H13N6O6P/c15-14-19-11-10(12(21)20-14)18-9(6-17-11)5-16-8-3-1-7(2-4-8)13(22)26-27(23,24)25/h1-4,6,16H,5H2,(H2,23,24,25)(H3,15,17,19,20,21)InChI=1S/C14H13N6O6P/c15-14-19-11-10(12(21)20-14)18-9(6-17-11)5-16-8-3-1-7(2-4-8)13(22)26-27(23,24)25/h1-4,6,16H,5H2,(H2,23,24,25)(H3,15,17,19,20,21)
DNKVHXNVVYQUDC-UHFFFAOYSA-NDNKVHXNVVYQUDC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02875' 'PF08245
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PD8 →
- PDB RCSB structure 1w78 →
- UniProt UniProt P08192 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PD8”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4808.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).